Article

Improve the Performance and Lower the Costs of ODT Drug Applications

J.T.Baker® PanExcea™ MC200G performance excipient from Avantor™ Performance Materials (formerly Mallinckrodt Baker) is engineered to reduce your cost-per-tablet.

J.T.Baker® PanExcea™ MC200G performance excipient from Avantor™ Performance Materials (formerly Mallinckrodt Baker) is an orally disintegrating tablet (ODT) building block enabling formulators to develop a direct compression ODT that disintegrates rapidly while offering good taste and texture. PanExcea™ MC200G offers a unique, dense spherical particle shape and morphology to maximize API loading capacity, blend flowability and taste-masking.

An excipient-based solution, PanExcea MC200G is also engineered to reduce cost-per-tablet because it can be produced using standard manufacturing and packaging equipment. This reduces or eliminates the costs of ODT technology licensing and new equipment investment. Read more.
Learn more: www.mallbaker.com/panexcea

Avantor™ Performance Materials
222 Red School Lane
Phillipsburg, NJ 08865
1-855-AVANTOR (within U.S.)
1-908-859-2151 (outside U.S.)
Fax: 908-859-6905

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content